Beth A. Tarini, M.D., M.S., M.B.A.

  • Associate Director, Center for Translational Research
    • B.A., Biology, Harvard University, Cambridge, MA (1993-1997)
    • M.D., Albert Einstein College of Medicine, Bronx, NY (1997-2001)
    • Residency, Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA (2001-2004)
    • Fellowship, Robert Wood Johnson Clinical Scholars, University of Washington, Seattle, WA (2004-2006)
    • M.S., Health Services, University of Washington, Seattle, WA (2004-2006)
  • Beth A. Tarini, M.D., M.S., M.B.A., conducts health services research that focuses on optimizing the delivery of genetic services to families and children, particularly newborn screening. Dr. Tarini's research has been funded by the National Institutes of Health, HRSA, the Robert Wood Johnson Foundation and the Cystic Fibrosis Foundation. 

    At the federal level she served as an appointed member of the Advisory Committee on Heritable Disorders in Newborns and Children, a committee which advises the Secretary of the U.S. Department of Health and Human Services on the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and standards. At the state level, she has served as chairwoman of the Michigan NBS Quality Assurance Advisory Committee and chairwoman-elect of the Iowa Congenital and Inherited Disorders Advisory Committee, both of which make newborn screening policy recommendations to state legislatures.

    Dr. Tarini is past president of the Society for Pediatric Research.